The debt reduction is a credit-positive signal that strengthens the balance sheet and reduces future dilution risk. Monitor for further repurchases or any update on cash runway, as the ~$29M cash outlay may impact near-term liquidity for a clinical-stage biotech.
Price Chart
Executive Summary
Omeros repurchased and retired $30.5 million aggregate principal amount of its 9.50% Convertible Senior Notes due 2029 in two tranches, including a $14.5 million repurchase completed on July 20, 2026 for ~$29.0 million (including accrued interest). Approximately $40.3 million in notes remain outstanding. The debt reduction lowers leverage, future interest expense, and potential equity dilution from conversion.
Key Facts
- Repurchased $14.5M principal of 9.50% Convertible Senior Notes due 2029 for ~$29.0M on July 20, 2026
- Combined with prior $16.0M repurchase, total retired is $30.5M aggregate principal
- Remaining outstanding notes: ~$40.3M principal
- Repurchases were privately negotiated with note holders
Financial Impact
Retired 43% of outstanding convertible notes ($30.5M of ~$70.8M originally outstanding), reducing annual interest expense by ~$2.9M and eliminating potential dilution from conversion of those notes
Risk Factors
- Cash used for repurchase (~$29M) could reduce funding available for R&D and operations
- Remaining $40.3M in convertible notes still represent potential dilution if converted
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-023886 |
| Document: 0001437749-26-023886-index-headers.html | 0001437749-26-023886 |
| Document: 0001437749-26-023886-index.html | 0001437749-26-023886 |
| Document: 0001437749-26-023886.txt | 0001437749-26-023886 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | Insider Cluster | $18.75 $19.04 | ▲ +1.55% | ▲ +1.44% | $18.30 (−2.40%) |
Aug 28, 2026 5w ago | Insider Cluster | $18.61 $19.43 | ▲ +4.41% | ▲ +4.15% | $18.30 (−1.67%) |
Aug 25, 2026 5w ago | Insider Cluster | $18.22 $20.13 | ▲ +10.48% | ▲ +10.26% | $18.30 (+0.44%) |
Aug 21, 2026 5w ago | Insider Cluster | $19.32 $21.05 | ▲ +8.95% | ▲ +7.64% | $18.30 (−5.28%) |
Jul 20, 2026 10w ago | 8-K | $9.53 $17.19 | ▲ +80.38% | ▲ +77.82% | $18.30 (+92.03%) |
Jul 6, 2026 12w ago | 8-K | $10.34 $11.84 | ▲ +14.51% | ▲ +15.07% | $18.30 (+76.98%) |
Jun 18, 2026 15w ago | 8-K | $10.28 $9.22 | ▼ −10.31% | ▼ −10.84% | $18.30 (+78.02%) |
Jun 11, 2026 16w ago | Institutional Cluster | $10.18 $10.27 | ▲ +0.88% | ▼ −1.01% | $18.30 (+79.76%) |
May 13, 2026 20w ago | 8-K | $13.28 $8.74 | ▼ −34.19% | ▼ −33.33% | $18.30 (+37.80%) |
Mar 31, 2026 26w ago | 8-K | $12.08 $14.56 | ▲ +20.53% | ▲ +10.81% | $18.30 (+51.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access